Interpace Biosciences Inc (IDXG) is a diagnostics & research company listed on OTCQX.
Latest reported IDXG revenue for 2026-06-30 was $18.2M. Net income was $879.0K. IDXG currently screens at market cap $43.5M and trailing P/E 1.8.
Use this IDXG page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IDXG quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IDXG SEC filings page. Lician reads the product cache first so this HTML stays unique to Interpace Biosciences Inc even when a live quote feed is slow.
Latest cached year on this hub. Full IDXG income, balance, and cash tables.